Genethon Presents 2-Year Efficacy Results of Low-Dose Micro-Dystrophin Gene Therapy (GNT0004) in Duchenne Muscular Dystrophy at ESGCT 2025 Genethon, a global leader in the research and development of gene therapies for rare genetic disorders, has reported encouraging long-term results from…
Thermo Fisher Scientific Launches Molecular Microscope Diagnostic System to Transform Lung Transplant Rejection Detection and Management Thermo Fisher Scientific Inc., the global leader in serving science, has unveiled an innovative laboratory-developed test (LDT) that aims to revolutionize the detection and…
Charles River and Toxys Partner to Advance NAM-Based Developmental Toxicity Testing Through ReproTracker® Collaboration Charles River Laboratories International, Inc. (NYSE: CRL) and Dutch biotechnology company Toxys have announced a strategic collaboration that aims to reshape the landscape of developmental and…
HealthTap Joins LillyDirect® to Expand Virtual Primary Care Access for Diabetes Management HealthTap, a leading provider of virtual primary care services in the United States, has announced that it will now be featured as an independent care provider option on…
Merz Therapeutics Strengthens European Footprint with Launch of New Affiliate in Poland Merz Therapeutics GmbH, a globally recognized leader in neurology-focused specialty pharmaceuticals, has officially announced the opening of its new affiliate in Warsaw, Poland. This strategic expansion marks a…
Kairos Pharma to Present Promising Phase 2 Prostate Cancer Data Highlighting Carotuximab’s Potential to Overcome Hormone Therapy Resistance at ESMO 2025 Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on developing novel cancer therapeutics that address treatment…
Allurion Publishes Landmark Peer-Reviewed Study Demonstrating Over 20% Total Body Weight Loss With Consecutive Use of Its Smart Capsule Allurion Technologies, Inc. (NYSE: ALUR), a global leader in developing innovative, non-surgical weight-loss solutions, announced a major milestone in the field…
Bimiralisib Topical PI3K/mTOR Inhibitor Demonstrates Up to 92% Clearance and Excellent Tolerability in Phase 2 Actinic Keratosis Trial Torqur AG, a clinical-stage biopharmaceutical company and a subsidiary of the Swiss Rockets AG incubator, has announced highly encouraging results from its…
Presto Dental Opens Flagship Multi-Specialty Practice in Bridgeport, Expanding Abra Health Group’s Connecticut Presence Presto Dental, a new and innovative dental brand affiliated with the Abra Health Group, has officially opened its first flagship location in Bridgeport, Connecticut. This milestone…
ENHERTU® Demonstrates Significant Superiority Over T-DM1 in DESTINY-Breast05 Phase 3 Trial for High-Risk HER2 Positive Early Breast Cancer Patients Positive topline results from the planned interim analysis of the DESTINY-Breast05 phase 3 clinical trial have reinforced the potential of ENHERTU®…
Lundbeck Partners with Migraine Community to Transform Care and Improve Lives Despite being recognized as one of the leading causes of disability worldwide, migraine remains widely misunderstood, and the profound impact it has on individuals’ daily lives is often underestimated…
Kardigan Accelerates Development of Transformative Cardiovascular Medicines Across Three Critical Disease Areas Kardigan, a pioneering heart health company dedicated to modernizing cardiovascular drug development, today unveiled the three late-stage clinical programs that anchor its rapidly advancing pipeline. These programs represent…